Reply to Letter to the Editor Regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five Year Real World Outcomes” by Meulmeester et al.

Nicholas J. Campion, Dioni‐Pinelopi Petsiou, Florian C. Fally, Karina Berbalk, Noah F. Melamed, Aldine Tu, Christina Morgenstern, Fana Alem Kidane, Mohammed Zghaebi, Linda Liu, Minghao Pan, Tina J. Bartosik, Victoria Stanek, Katarina Gangl, Julia Eckl‐Dorna, Sven Schneider
International Forum of Allergy and Rhinology · Wiley · 2026-11-04 · DOI: 10.1002/alr.70293

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles